Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)

This publication has 20 references indexed in Scilit:

• Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase
  Bioorganic & Medicinal Chemistry Letters, 2007
• PARP Inhibitor Development for Systemic Cancer Targeting
  Anti-Cancer Agents in Medicinal Chemistry, 2007
• Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling
  Bioorganic & Medicinal Chemistry, 2006
• Poly(ADP‐ribose)
  The FEBS Journal, 2005
• PARP-1 inhibition to treat cancer, ischemia, inflammation
  Pharmacological Research, 2005
• The role of poly(ADP-ribose) in the DNA damage signaling network
  Biochemistry and Cell Biology, 2005
• The PARP superfamily
  BioEssays, 2004
• Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling
  Trends in Pharmacological Sciences, 2004
• Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361
  JNCI: Journal of the National Cancer Institute, 2004
• Design and Synthesis of Poly ADP-ribose Polymerase-1 Inhibitors. 2. Biological Evaluation of Aza-5[H]-phenanthridin-6-ones as Potent, Aqueous-Soluble Compounds for the Treatment of Ischemic Injuries
  Journal of Medicinal Chemistry, 2003